Atopic dermatitis (AD) is a common, chronic inflammatory skin condition, and patients with moderate-to-severe disease often require systemic therapy. Since 2017, targeted systemic agents, biologics and Janus kinase (JAK) inhibitors, have expanded treatment options available, but comparative evidence remains limited...
Vasiliki Pikoula, E. Zafiriou, A. Bewley et al.· Frontiers in Immunology· 0 citations
Hidradenitis suppurativa (HS) is a chronic, recurrent and progressively destructive inflammatory disease associated with substantial physical, psychological and social burden. The therapeutic landscape of HS has rapidly evolved with the introduction of biologics targeting TNF-α and IL-17 pathways, increasing use of met...
L. Matusiak, Magdalena Dzięgała, Brian Kirby et al.· Journal of the European Acad...· 0 citations
Background/Objectives: Patients with melanoma may experience depression and anxiety, but their relationship with dermatology-related quality of life (QoL) remains insufficiently characterized. This study assessed depressive and anxiety symptoms and their associations with QoL, sex, disease stage, and time since diagnos...
Maja Hrynczyszyn, Michalina Świetlicka, Paulina Piesch et al.· Journal of Clinical Medicine· 0 citations
Evidence drawn from predominantly young adult White women has shown that the prevalence of TBA varies widely depending on the diagnostic criteria employed, and individuals meeting criteria for TBA are at heightened risk for multiple psychological conditions.
S. Nochaiwong, C. Ruengorn, R. Awiphan et al.· Journal of the European Acad...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
